Multiplex Assays Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Based on end-user, the global multiplex assays market has been classified into biotechnology & biopharmaceutical companies, academic & research centers, diagnostic centers, hospitals, and others. The biotechnology & biopharmaceutical companies segment is anticipated to expand at a significant CAGR during the forecast period. The market has been analyzed based on price variations, technology trend, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Multiplex Assays Market: Regional Outlook

In terms of region, the global multiplex assays market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key companies profiled in the global multiplex assays market include Luminex Corporation, Thermo Fisher Scientific, Inc., Seegene, Inc., Meso Scale Diagnostics, LLC., Abcam plc, Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Quansys Biosciences, and Illumina, Inc.

The global multiplex assays market has been segmented as follows:

Global Multiplex Assays Market, by Product
Instruments
Consumables
Reagents & Kits
Micropipettes & Microplates
Others
Software

Global Multiplex Assays Market, by Technology
Multiplex RT-PCR
Flow Cytometry
Luminescence
Fluorescence
Others

Global Multiplex Assays Market, by Type
Protein
Planar
Bead-based
Nucleic Acid
Planar
Bead-based
Cell

Global Multiplex Assays Market, by Application
Research & Development
Drug Discovery & Research
Biomarker Research & Application
Diagnosis
Infectious Diseases
Autoimmune Diseases
Cancer
Cardiovascular Diseases
Neuro-endocrine Diseases
Others
Others

Global Multiplex Assays Market, by End-user
Biotechnology & Biopharmaceutical Companies
Academic & Research Centers
Diagnostic Centers
Hospitals
Others

Global Multiplex Assays Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Israel
Rest of Middle East & Africa

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.